Vetanco International Acknowledgment for Sherry Layton, Vetanco Scientific Director

Sherry Layton, Vetanco Scientific Director, will be awarded in the 12th International Conference on Emerging Infectious Diseases

Vaccines Conference-2022, Global Conference on Vaccines Research and Development

PDF) Interaction of genotype and diet on small intestine microbiota of Japanese quail fed a cholesterol enriched diet

Sherry Layton - Chief Executive Officer - Vetanco USA

Frontiers Evaluation of a Novel Mucosal Administered Subunit Vaccine on Colostrum IgA and Serum IgG in Sows and Control of Enterotoxigenic Escherichia coli in Neonatal and Weanling Piglets: Proof of Concept

Vaccines Conference-2022, Global Conference on Vaccines Research and Development

Vaccines Conference-2022, Global Conference on Vaccines Research and Development

Frontiers A Role for the Non-Canonical Wnt-β-Catenin and TGF-β Signaling Pathways in the Induction of Tolerance during the Establishment of a Salmonella enterica Serovar Enteritidis Persistent Cecal Infection in Chickens

Frontiers Biosurveillance of avian influenza and Newcastle disease viruses in the Barda region of Azerbaijan using real time RT-PCR and hemagglutination inhibition

Vetanco International Acknowledgment for Sherry Layton, Vetanco Scientific Director

Vetanco Vetanco's presence at the Latin American Scientific Conference

News - BV Science

Sherry Layton - Chief Executive Officer - Vetanco USA